SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001126234-22-000066
Filing Date
2022-05-11
Accepted
2022-05-11 13:01:16
Documents
46
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nlnk-20220331.htm   iXBRL 10-Q 1046353
2 EX-31.1 lumo-2022331x10qxex311.htm EX-31.1 10124
3 EX-31.2 lumo-2022331x10qxex312.htm EX-31.2 10175
4 EX-32.1 lumo-2022331x10qxex321.htm EX-32.1 7160
10 nlnk-20220331_g1.jpg GRAPHIC 12762
11 nlnk-20220331_g2.jpg GRAPHIC 111679
  Complete submission text file 0001126234-22-000066.txt   3707563

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nlnk-20220331.xsd EX-101.SCH 24038
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nlnk-20220331_cal.xml EX-101.CAL 32913
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nlnk-20220331_def.xml EX-101.DEF 89345
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nlnk-20220331_lab.xml EX-101.LAB 309099
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nlnk-20220331_pre.xml EX-101.PRE 179457
40 EXTRACTED XBRL INSTANCE DOCUMENT nlnk-20220331_htm.xml XML 316378
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35342 | Film No.: 22912919
SIC: 2834 Pharmaceutical Preparations